Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

New therapies are being developed that target integrin pathways to treat various diseases.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

A new mouse model for vitiligo helps study immune responses and potential treatments.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Immune activities and specific genes are important in male pattern baldness.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

Minoxidil can help regrow hair in alopecia areata patients.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

A group has developed therapies that show promise for treating cancer and various other conditions.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.